Immatics NV
NASDAQ:IMTX
Immatics NV
Cash from Financing Activities
Immatics NV
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immatics NV
NASDAQ:IMTX
|
Cash from Financing Activities
€84.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Financing Activities
-€778.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Financing Activities
€43m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-11%
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Financing Activities
€230.9m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Cash from Financing Activities
-€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Cash from Financing Activities
€40.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
See Also
What is Immatics NV's Cash from Financing Activities?
Cash from Financing Activities
84.5m
EUR
Based on the financial report for Dec 31, 2023, Immatics NV's Cash from Financing Activities amounts to 84.5m EUR.
What is Immatics NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
29%
Over the last year, the Cash from Financing Activities growth was -32%. The average annual Cash from Financing Activities growth rates for Immatics NV have been -26% over the past three years , 29% over the past five years .